ABOUT CO.DON

We are a biopharmaceutical company and one of the leading manufacturers of cell transplants.

WE FOCUS ON PERSONALISED CELL THERAPIES FOR THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS

We specialise in the development and manufacture of cell therapies for the regenerative treatment of articular cartilage defects using only the patient’s own cartilage cells. Our cell therapies are a regenerative method that in many cases makes it possible to avert or postpone the need for joint replacement surgery. Our therapies are classified as prescription-only medicinal products and are increasingly used on a day-to-day basis in hospitals by orthopaedic and accident surgeons.

Our production facility offers modern technology for the cultivation of human cells – for the production of our own products and for contract manufacturing.

Our more than 100 employees come from many very different professional backgrounds - scientists, researchers, manufacturing and quality control specialists, engineers, experts for regulatory affairs, clinical trials, market access, communication and many other areas. Together they work every day to ensure that our company is a reliable partner for the physicians using our products in hospitals. Hand in hand, they guarantee the highest product quality for the benefit of patients and contract manufacturing customers.

WHAT WE WANT, WHAT WE ANSWER FOR AND WHAT GUIDES US

As experts for human cells we want to provide a regenerative, personalised treatment for every patient using their own cells, which enables them to enjoy an active life. Our mission and vision statements express this: they sum up what we strive for and the commitments we make in our daily work. Our company values define the core elements of our corporate culture and thus what is important to us in our daily work as well as when cooperating with our colleagues and customers.

OUR VISION

We empower every patient to be healed with their own cartilage cells, because we are the human cell experts.

 

OUR MISSION

Our mission is to offer a personalized cartilage repair so you can continue your active life.

which means for us: We respect different opinions and cultures inside and outside our company.

which means for us: We enable and value small and big successes and learn from our mistakes.

which means for us: We communicate openly and honestly with each other. We explain our actions and stand by our actions.

which means for us: We clearly communicate goals and empower employees to make independent and timely decisions.

OUR HISTORY

Established as a research-focused biotechnology company, we have since 2016 developed into a commercial biopharmaceutical, product-based company. In line with our mission and vision, we are currently working to make our cell therapies available not only to patients in Germany and the European Union, but also to other countries in Europe and beyond.

1993

Establishment of co.don GmbH in Teltow (focus: contract research)

1997

First company in Germany to receive manufacturing licence for autologous cell transplants under Section 13 German Pharmaceuticals Act (AMG); first patient

1999

Development of independent manufacturing technology – Integrated Isolator Technology (IIT) – and operational launch of proprietary cleanroom production plant

2001

co.don GmbH becomes CO.DON AG, initial public offering (IPO) on 14 February 2001

2010

Start of clinical trials phase II and phase III

2017

EU authorisation received and start of EU expansion; construction starts on new production site in Leipzig

2018

End of clinical trial phase II

2019

co.don schweiz gmbh: regulatory approval in Switzerland

2020

Manufacturing license for own and contract production at Leipzig site

OUR SITES

Our presence in Germany comprises one production and development site in Teltow and one administrative office in Berlin. A further production site is located in Leipzig, for which we have been granted a manufacturing license for in-house and contract production in 2020. In addition, we have operations in the following European countries via subsidiaries or distribution partnerships: Switzerland (co.don schweiz gmbh), Netherlands (CO.DON NL B.V.), Austria and England (CO.DON UK Ltd.).